5.4 Social Anxiety Disorder – Diagnostic Criteria, Epidemiology, Etiology & Treatment
DSM-5 Diagnostic Criteria for Social Anxiety Disorder (Social Phobia)
- Core feature: Marked fear or anxiety about one or more social situations in which the individual may be scrutinized, evaluated, or judged by others.
- Typical situations:
- Conversations, meeting unfamiliar people, dating, interviews.
- Being observed eating or drinking.
- Performing in public (e.g., giving a speech).
- Children-specific requirement: Anxiety must occur in peer settings, not only with adults.
- Criterion B – Fear of negative evaluation:
- Person worries they will act in a way, or display symptoms, that will be humiliating, embarrassing, offensive, or lead to rejection.
- Criterion C – Social situations almost always provoke fear/anxiety.
- In children, may manifest as crying, tantrums, freezing, clinging, shrinking, or failing to speak.
- Criterion D – Situations are avoided, or endured with intense fear/anxiety.
- Criterion E – Fear/anxiety is out of proportion to the actual threat and to socio-cultural context.
- Criterion F – Persistence: typically ≥6 months.
- Criterion G – Causes clinically significant distress or impairment in social, occupational, or other important areas.
- Criterion H – Not attributable to physiological effects of a substance or another medical condition.
- Criterion I – Not better explained by another mental disorder (e.g., panic disorder, body-dysmorphic disorder, autism spectrum disorder).
- Criterion J – If a separate medical condition is present (e.g., obesity, disfigurement, burns), the fear is clearly unrelated or excessive.
- Specifier – “Performance only”: Anxiety is restricted to speaking/performing in public (e.g., public speaking).
Epidemiology & Demographics
- Lifetime prevalence: 12% of the general population.
- Sex ratio: ~60% of diagnosed cases are women.
- Typical age of onset: Early adolescence to early adulthood.
Comorbidity & Functional Impact
- Anxiety disorders: Nearly 32 of individuals have ≥1 additional anxiety disorder across the lifespan.
- Depressive disorders: ≈50% have a concurrent depressive disorder.
- Alcohol use: ≈31 abuse alcohol, often as self-medication before social events ("liquid courage").
- Employment & SES: On average, lower employment rates, lower socioeconomic status; ≈31 show severe impairment in ≥1 life domain.
- Course: Highly persistent; only ≈31 recover spontaneously over 12 years (vs. higher spontaneous-recovery rates in disorders such as major depression).
- Network perspective: Comorbid patterns (e.g., anxiety + alcohol use) suggest overlapping causal networks rather than fully independent “diseases.”
Etiology: Psychological Factors
- Classical conditioning
- Direct trauma: Being the target of anger, criticism, or humiliation can serve as an unconditioned stimulus that pairs social cues with fear.
- Two studies: 56−58% of those with social anxiety recalled a direct traumatic social experience at onset (Augustine & H. Ø. 1981; Townley et al., 1995).
- Vicarious conditioning: Observing others being criticized/humiliated can also trigger learning.
- Laboratory evidence: Fear conditioning is stronger when conditioned stimuli are social (critical face, harsh words) vs. nonsocial (bad odor, pressure pain).
- Childhood teasing/bullying
- 92% of adults with social anxiety reported severe childhood teasing vs. 35% of an OCD comparison group (McCabe et al., 2003).
Etiology: Biological & Temperamental Factors
- Behavioral inhibition (BI)
- Temperamental tendency to be easily distressed by novelty; overlaps with neuroticism & introversion.
- Infants high in BI → more shyness, avoidance; by adolescence, elevated risk for social anxiety disorder.
- Longitudinal data (Hayward et al., 1998; Taddon et al., 1997): Children rated high on BI at ages 2−6 were 3× more likely to be diagnosed with social anxiety in middle childhood (22 % vs. 8 %).
- Genetics
- Twin/genetic studies = modest heritability; estimates h2≈0.12−0.30.
- The majority of variance stems from non-shared environmental factors, dovetailing with learning findings.
Treatment Approaches
- Exposure-based behavioral therapy
- Graduated (step-wise) exposure to feared social situations; parallels specific-phobia treatment.
- Cognitive restructuring (part of CBT)
- Identify automatic negative thoughts ("I have nothing interesting to say", "Everyone will think I’m stupid").
- Use logical re-analysis questions:
- “Do I know for certain I will have nothing to contribute?”
- “Does visible nervousness necessarily lead to rejection?”
- Goal: Replace distorted appraisals with balanced cognitions.
- Efficacy
- CBT (exposure + cognitive restructuring) often outperforms pharmacotherapy and yields longer-lasting gains with low relapse.
- Clients may continue to improve post-treatment.
- Pharmacotherapy
- Antidepressants (MAOIs, SSRIs, SNRIs) can reduce symptoms.
- Require long-term use to prevent relapse; overall effect sizes often smaller vs. modern CBT protocols.
- Augmentation strategies
- Adding social-skills training or assertiveness training can accelerate and potentiate gains.
- Combining pharmacotherapy with CBT sometimes helpful, but CBT alone usually suffices.
Practical, Ethical, & Societal Considerations
- Ethical: Clinicians must differentiate culturally normative shyness from clinically impairing social anxiety to avoid pathologizing introversion or cultural restraint.
- Philosophical: The network-symptom viewpoint challenges categorical diagnosis; encourages a dimensional, mechanistic understanding (e.g., anxiety ↔ alcohol use feedback loops).
- Public-health relevance: Given early onset, persistence, and functional impairment, early identification (e.g., screening shy/inhibited children) and school-based interventions may lessen lifelong burden.